Last Updated: 04/16/2016 01:33:27
CORE Stock Chart - 1 Month
CORE Stock Chart - 3 Month
CORE Stock Chart - 6 Month
CORE Stock Chart - 1 Year
CORE Stock Chart - 2 Year
Where Energy Drinks and Digital Reality Collide Monster Energy sure knows how to throw a party, especially when it hinges on something as electrifying as Call of Duty: Modern Warfare 4. Imagine this: Cosm Los Angeles is decked out with a massive 87-foot LED dome, and every gamer, celeb, and influencer ready to dive right in. You can't make this stuff up. They've mashed...
Continue Reading
Sinclair Television Caught in Labor Law Storm When you think of flaring tempers and boardroom brawls, you typically don't think of your everyday TV station. But right now, Sinclair Television of California, LLC is in the hot seat, accused of playing fast and loose with wage packets—specifically, allegedly denying meal periods and rest breaks that California labor laws...
Continue Reading
A Star-Studded Start to the Season of Giving Miranda Lambert is set to dazzle audiences yet again, and if there's one thing this country music titan knows, it's how to crank up the heartstrings while fanning the flames of generosity. She'll take to the stage at AT&T Stadium this Thanksgiving during the Dallas Cowboys game, bringing a powerful performance to light up the...
Continue Reading
A Festive Transformation at CARNE Rolling into Oxnard, you're met with an unconventional dining spectacle at CARNE. It's not your average restaurant fare as they've pulled out the stops with their spirited Halloween pop-up, A Nightmare at CARNE. Channeling the eerie charm of "The Nightmare Before Christmas," this temporary transformation morphs the venue into a lively,...
Continue Reading
A New Era in Lung Cancer Treatment? Sac-TMT, the novel antibody-drug conjugate (ADC), just might be shaking up the non-small cell lung cancer (NSCLC) treatment landscape, and boy, is it making waves. Just when you think you’ve seen it all, here comes sacituzumab tirumotecan (sac-TMT), offering a glimmer of hope for patients whose treatment options have dwindled after...
Continue Reading
The Heartbeat of Innovation in Cancer Therapy Who would've thought Tennessee would be at the forefront of a global push against lung cancer? Sure, there's Nashville's music scene, but it's the researchers at Tennessee Oncology who are grooving to a different beat—one that might just set the rhythm for advanced cancer therapies worldwide. Yeah, it's a trial, but not just...
Continue Reading
Innovent Lauds HER2 ADC's Moment at ESMO 2026 Alright, chin up, investors. At the 2026 ESMO Congress, Innovent's throwing down some promising Phase 2 data for their brainchild, IBI354. You hear that name and it's like hearing about a rock star in the making in the oncology world. The potential here isn’t just talk—it's a loud, resounding call for attention. Their...
Continue Reading
The Ripple Effect of Tragedy Grief has a way of shaking a community down to its core—especially when the loss emanates from such senseless violence as the shooting death of 17-year-old Levi Brown. This wasn't just a tragic occurrence at a Friday night football game in Bakersfield; it was a visceral crack in the perceived safety of community events. Levi's Legacy and...
Continue Reading
Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...
Continue Reading
LexisNexis Takes a Serious Step Forward The world of law enforcement reporting just got a shake-up. LexisNexis Coplogic Solutions launched a souped-up version of its Desk Officer Reporting System (DORS) at the IACP 2026 event. They paired DORS with Field Clarity, a newfangled AI-powered assistant that aims to make police reporting slicker and more accurate. You can bet...
Continue Reading
EXL Announces 2024 Financial Results Release Date ExlService Holdings, Inc. (NASDAQ: EXLS), a prominent global player in the data and artificial intelligence sector, is gearing up to reveal its financial results for the fourth quarter and full year ending in December 2024. This important announcement will occur on a Tuesday afternoon, specifically on the 25th of February,...
Continue Reading
Jefferies Financial Group Inc. (NYSE: JEF) rolled out its plan for the upcoming Investor Day scheduled for October 21, 2024. This event is set against the vibrant backdrop of Manhattan, making it a key date for traders and investors alike who are looking to gauge the firm’s strategic direction and operational pulse. Investor Day Insights: What Traders Should Know The...
Continue Reading
Investor Alert on Atkore Inc. Bragar Eagel & Squire, P.C., a respected law firm specializing in shareholder rights, is actively investigating Atkore Inc. (NASDAQ: ATKR) on behalf of long-term stockholders. This inquiry arises in light of concerning allegations that may affect investors who hold or have held Atkore shares during a defined period. Current Investigation...
Continue Reading
Revolutionizing Dust Management in Construction Innovators are continually seeking ways to enhance worksite safety and efficiency in the construction industry. One such inventor from Altoona has made significant strides by developing a novel dust management system known as THE DUST DOME. This invention stems from the personal experiences of a tile installer who recognized...
Continue Reading
MYR Group Inc. Reports Impressive Financial Gains THORNTON, Colo. — MYR Group Inc. (NASDAQ: MYRG), a leading provider of specialized electrical contracting services across North America, revealed outstanding financial results for the second quarter and first half of 2025 earlier today. The Company achieved a remarkable revenue growth of $900.3 million in the second...
Continue Reading